Tag Archives: Rodin Therapeutics

Thinking Boldly: Alkermes Acquires Rodin Therapeutics
November 18, 2019

Today Alkermes announced its acquisition of Rodin Therapeutics, a leader in the field of synaptic dysfunction and neuronal epigenetics. Alkermes extensive experience in CNS diseases made them an ideal partner for Rodin, and this acquisition helps expand Alkermes’ efforts into

Leave a comment

A New Translational Tool for Synaptopathies
October 19, 2018

This blog was written by Adam Rosenberg, CEO of Rodin Therapeutics, as part of the From The Trenches feature of LifeSciVC. After decades of challenges in neuroscience research and development, there is new hope that we can design better clinical

Leave a comment